JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB274913

Human CD19 knockout Raji cell line

Be the first to review this product! 리뷰 제출

|

(0 출판물)

Human CD19 knockout Raji cell line (ab274913) available to order. Recommended control: Human wild-type Raji cell line (ab271145).

- CD19 KO validation: Next Generation Sequencing (NGS)
- Concentration: 1 million cells/vial

대체 명칭 보기

CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen B4

6 이미지
Next Generation Sequencing - Human CD19 knockout Raji cell line (AB274913)
  • NGS

Supplier Data

Next Generation Sequencing - Human CD19 knockout Raji cell line (AB274913)

Knockout achieved by CRISPR/Cas9; X = 2 bp deletion; Frameshift : 100%

Western blot - Human CD19 knockout Raji cell line (AB274913)
  • WB

Lab

Western blot - Human CD19 knockout Raji cell line (AB274913)

Western blot : Anti-CD19 antibody [RM1166] ab317335 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 80-90 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD19 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-CD19 antibody [RM2072] (<a href='/ko/products/primary-antibodies/cd19-antibody-rm2072-ab322345'>ab322345</a>) at 1/1000 dilution

Lane 1:

Wild-type Raji at 20 µg

Lane 2:

Western blot - Human CD19 knockout Raji cell line (ab274913) at 20 µg

Lane 3:

Ramos at 20 µg

Lane 4:

MCF7 at 20 µg

Lane 5:

Daudi at 20 µg

Lane 6:

Jurkat at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 80-90 kDa

Observed band size: 80-90 kDa

false

Western blot - Human CD19 knockout Raji cell line (AB274913)
  • WB

Lab

Western blot - Human CD19 knockout Raji cell line (AB274913)

Western blot : Anti-CD19 antibody [EPR5906] ab134114 staining at 1/10000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 80-90 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD19 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-CD19 antibody [EPR5906] (<a href='/ko/products/primary-antibodies/cd19-antibody-epr5906-ab134114'>ab134114</a>) at 1/10000 dilution

Lane 1:

Wild-type Raji at 20 µg

Lane 2:

Western blot - Human CD19 knockout Raji cell line (ab274913) at 20 µg

Lane 3:

Ramos at 20 µg

Lane 4:

MCF7 at 20 µg

Lane 5:

Daudi at 20 µg

Lane 6:

Jurkat at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 80-90 kDa

Observed band size: 80-90 kDa

false

Western blot - Human CD19 knockout Raji cell line (AB274913)
  • WB

Lab

Western blot - Human CD19 knockout Raji cell line (AB274913)

Western blot : Anti-CD19 antibody [SP291] - C-terminal ab227688 staining at 1/400 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 80-90 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD19 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-CD19 antibody [SP291] - C-terminal (<a href='/ko/products/primary-antibodies/cd19-antibody-sp291-c-terminal-ab227688'>ab227688</a>) at 1/400 dilution

Lane 1:

Wild-type Raji at 20 µg

Lane 2:

Western blot - Human CD19 knockout Raji cell line (ab274913) at 20 µg

Lane 3:

Ramos at 20 µg

Lane 4:

MCF7 at 20 µg

Lane 5:

Daudi at 20 µg

Lane 6:

Jurkat at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 80-90 kDa

Observed band size: 80-90 kDa

false

Western blot - Human CD19 knockout Raji cell line (AB274913)
  • WB

Lab

Western blot - Human CD19 knockout Raji cell line (AB274913)

Western blot : Anti-CD19 antibody [RM1166] ab317335 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 80-90 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD19 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-CD19 antibody [RM1166] (<a href='/ko/products/primary-antibodies/cd19-antibody-rm1166-ab317335'>ab317335</a>) at 1/1000 dilution

Lane 1:

Wild-type Raji at 20 µg

Lane 2:

Western blot - Human CD19 knockout Raji cell line (ab274913) at 20 µg

Lane 3:

Ramos at 20 µg

Lane 4:

MCF7 at 20 µg

Lane 5:

Daudi at 20 µg

Lane 6:

Jurkat at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 80-90 kDa

Observed band size: 80-90 kDa

false

Western blot - Human CD19 knockout Raji cell line (AB274913)
  • WB

Lab

Western blot - Human CD19 knockout Raji cell line (AB274913)

Western blot : Anti-CD19 antibody [4C7] ab288365 staining at 1/2000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 80-90 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD19 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-CD19 antibody [4C7] (<a href='/ko/products/primary-antibodies/cd19-antibody-4c7-ab288365'>ab288365</a>) at 1/2000 dilution

Lane 1:

Wild-type Raji at 20 µg

Lane 2:

Western blot - Human CD19 knockout Raji cell line (ab274913) at 20 µg

Lane 3:

Ramos at 20 µg

Lane 4:

MCF7 at 20 µg

Lane 5:

Daudi at 20 µg

Lane 6:

Jurkat at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 80-90 kDa

Observed band size: 80-90 kDa

false

주요 정보

세포 유형

Raji

Species or organism

Human

조직

Lymphatic

제형

Liquid

form

Knockout 검증

Next Generation Sequencing,Western blot

Mutation 정보

Knockout achieved by CRISPR/Cas9 X = 2 bp deletion Frameshift: 100%

질병

Lymphoma

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

제품 세부 정보

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab274913-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab271145 Human wild-type Raji cell line", "number":"AB274913-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab274913 Human CD19 knockout Raji cell line", "number":"AB274913-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab274913-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab274913 Human CD19 knockout Raji cell line", "number":"AB274913-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
CD19
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Next Generation Sequencing, Western blot
배송 시 보관 조건
Dry Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
-196°C|-80°C
적절한 장기 보관 조건
-196°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

CD19 is a transmembrane protein also known as B4 or B-lymphocyte antigen CD19 with an approximate molecular weight of 95 kDa. It is expressed on the surface of B cells throughout their development from pro-B cells to mature B cells. CD19 functions mechanically as a coreceptor enhancing the sensitivity of B cell receptor (BCR) signaling. This protein plays a significant role in promoting the activation and proliferation of B cells by lowering the threshold for antigen receptor engagement.
Biological function summary

CD19 acts as an essential player in B cell signaling. CD19 integrates signals from the BCR with other coreceptors acting as a signaling hub. It participates in forming a signaling complex that includes proteins like CD21 and CD81 which further amplifies BCR-mediated signaling. This complex plays a critical role in B cell activation differentiation and survival ensuring that immune responses are efficiently mounted against pathogens.

Pathways

The CD19 protein fits into key immune response pathways such as the BCR signaling pathway and the PI3K-Akt signaling pathway. CD19 collaborates with other proteins like CD21 CD81 and PI3K within these pathways. Its interaction in the PI3K-Akt pathway for instance supports critical processes including B cell activation and homeostasis contributing to the adaptive immune response.

CD19 is connected to B cell malignancies and autoimmune diseases. B cell acute lymphoblastic leukemia (ALL) often shows aberrant CD19 expression making it a valuable target for therapeutic interventions like anti-CD19 monoclonal antibodies. Additionally overexpression or mutations of CD19 may contribute to autoimmune diseases by disrupting normal B cell regulation. CD19's connection with proteins like CD22 and CD20 in these pathological contexts highlights its relevance in developing targeted therapies.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Suspension

초기 취급 지침

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water for bath approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method. Based on cell count, seed cells in an appropriate cell culture flask at a density of 4x10<sup>5</sup> - 5x10<sup>5</sup> cells/mL(for initial passages it is recomended to culture the cells in the higher range of recomended seeding density). Seeding density is given as a guide only and should be scaled to align with individual lab schedules.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Cultures should be monitored daily.</p>

Subculture 가이드라인
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 4x105 cells/mL is recommended.
  • A maximum of 3x106 viable cells/mL is obtainable.
배양 배지

RPMI + 10% FBS

동결보존 배지

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com